Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy by Volker Schirrmacher, Stefaan van Gool, Wilfried Stuecker

Get full text

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy by Volker Schirrmacher, Stefaan van Gool, Wilfried Stuecker

Get full text

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit by Volker Schirrmacher, Tobias Sprenger, Wilfried Stuecker, Stefaan W. Van Gool

Get full text

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged by Stefaan W. Van Gool, Jennifer Makalowski, Simon Fiore, Tobias Sprenger, Lothar Prix, Volker Schirrmacher, Wilfried Stuecker

Get full text

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience by Stefaan W. Van Gool, Jennifer Makalowski, Peter Van de Vliet, Stefanie Van Gool, Tobias Sprenger, Volker Schirrmacher, Wilfried Stuecker

Get full text

Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience by Stefaan W. Van Gool, Jennifer Makalowski, Erin R. Bonner, Oliver Feyen, Matthias P. Domogalla, Lothar Prix, Volker Schirrmacher, Javad Nazarian, Wilfried Stuecker

Get full text